
Aortic stenosis (AS) and coronary artery disease (CAD) often coexist, presenting complex treatment challenges. While surgical aortic valve replacement (SAVR) with coronary artery bypass grafting (CABG) has improved outcomes in severe CAD, transcatheter aortic valve replacement (TAVR) has expanded options. Revascularization strategies include PCI before, during, or after TAVR. Treatment selection depends on disease severity, antithrombotic strategies, and symptom evolution, necessitating tailored, multidisciplinary approaches.
Like
Save
Share